Pre-Open Stock Movers 09/16: (DEPO) (INTC) (GPRO) Higher; (NVAX) (DB) (ORCL) Lower (more...)
- Record-setting rally pushes on as S&P ends week up 3 percent
- Trump's Cohn Pick Most Bullish Sign Yet for Banks - Cowen
- Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Today's After-Hours Movers:
Novavax, Inc., (Nasdaq: NVAX) 83% LOWER; announced topline data from two clinical trials of its RSV F-protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) in older adults. The Resolve trial, a Phase 3 trial of our RSV F Vaccine in 11,856 older adults (60 years of age and older), did not meet the pre-specified primary or the secondary efficacy objectives, and did not demonstrate vaccine efficacy. Consistent with our previous clinical experience, the vaccine was well tolerated.
Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) 14.6% HIGHER; announced that the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion for a new Lymphoseek® 50 microgram kit for radiopharmaceutical preparation. Lymphoseek is a medicinal product for diagnostic use only and is indicated in the EU for imaging and intraoperative detection of sentinel lymph nodes draining a primary tumor in adult patients with breast cancer, melanoma, or localized squamous cell carcinoma of the oral cavity.1 This new Lymphoseek dose packaging enables a single injection per patient and is appropriate for the radiopharmaceutical distribution model in Europe.
Depomed (Nasdaq: DEPO) 13% HIGHER; reports from Reuters the company is preparing to sell itself amid pressure from activist investorStarboard Value LP.
Deutsche Bank (NYSE: DB) 9% LOWER; Asked to Pay $14B to Settle U.S. Probe into Mortgage Securities
Alimera Sciences (NASDAQ: ALIM) 7.9% HIGHER; Cowen upgraded from Market Perform to Outperform with a price target of $3.00.
Capricor Therapeutics, Inc. (NASDAQ: CAPR) 7% LOWER; announced that it intends to offer shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Roth Capital Partners and National Securities Corporation, a wholly-owned subsidiary of National Holdings, Inc., are acting as joint book-running managers for the offering.
comScore, Inc. (NASDAQ: SCOR) 6.4% HIGHER; restates 2015
GoPro (NASDAQ: GPRO) 4.1% HIGHER; BofA/Merrill Lynch initiated coverage with a Buy rating and a price target of $19.00.
Intel Corporation (Nasdaq: INTC) 3.9% HIGHER; announced that third-quarter revenue is expected to be above the company's previous outlook. The company now expects third-quarter revenue to be $15.6 billion, plus or minus $300 million, as compared to the previous range of $14.9 billion, plus or minus $500 million. The increase in revenue is primarily driven by replenishment of PC supply chain inventory. The company is also seeing some signs of improving PC demand. *** The Street was looking for Q3 revenue of $14.9 billion.
Twitter (NYSE: TWTR) 3.7% HIGHER; successful NFL broadcast on Thursday night.
AMD (NYSE: AMD) 3.5% HIGHER; gains on Intel news.
Oracle (NYSE: ORCL) 3% LOWER; reported Q1 EPS of $0.55, $0.03 worse than the analyst estimate of $0.58. Revenue for the quarter came in at $8.6 billion versus the consensus estimate of $8.7 billion. Sees Q2 constant currency EPS of $0.59-$0.62 vs consensus of $0.65. Q2 total revenue is seen at unchanged to up 3%.
Travelport (NYSE: TVPT) 1.9% LOWER; announced that certain of the Company's shareholders (the "Selling Shareholders") intend to offer in an underwritten public offering an aggregate of 7,986,979 of the Company's common shares (the "Offering"). The offering consists entirely of secondary shares to be sold by the Selling Shareholders. The Company will not receive any of the proceeds from the shares sold in the Offering.
Citigroup (NYSE: C) 1.2% LOWER; Goldman Sachs downgrades to Neutral
21st Century Fox (NASDAQ: FOXA) 0.9% LOWER; Bernstein downgraded from Outperform to Market Perform with a price target of $26.00 (from $33.00).
Pandora (NYSE: P) 0.8% HIGHER; announced a direct licensing agreement for recorded music with Warner Music Group. This agreement enables both companies to support artists and satisfy the full range of music listening experiences for consumers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pre-Open Stock Movers 12/08: (VYGR) (TLRD) (LULU) Higher; (OHRP) (VRNT) (CMTL) Lower (more...)
- BofA/Merrill Lynch Upgrades AMD (AMD) to Buy
- BofA/Merrill Lynch Downgrades Barclays (BCS) to Underperform
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesDeutsche Bank, Goldman Sachs, Citi, Merrill Lynch, Bank of America, Sanford C. Bernstein, Roth Capital, Standard & Poor's, Twitter, Cowen & Co, After-Hours Movers, Pre-Open Losers, Pre-Open Winners, Pre Market Movers
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!